Family Medicine

Expert psychiatrist Dr. Timothy Fong explains the complexity of using marijuana as treatment in a primary care setting and shares advice on how to address it with patients.

Patients who demonstrated high trough concentrations early on in treatment were more likely to achieve remission by weeks 14 or 52.

Subcutaneous administration of the gut-selective treatment was notably well-tolerated, safe, and cost-effective.

Maternal-fetal medicine specialist Dr. Michael Aziz shines a light on the leading complications for pregnant patients and why the US has the highest maternal mortality rate.

Dr. Shirah Vollmer and Dr. Michael Ziffra host a Question & Answer Session addressing common inquiries about mental health treatment in the primary care setting.

Theresa R. Cerulli, MD, discusses the known clinical profile and evidential potential of the newest non-stimulant ADHD drug for adults.

On the heels of the FDA approval of viloxazine extended-release capsules for adult ADHD, a neuropsychiatrist discusses the state of care and diagnosis among older patients.

Amid major national judicial and legislative deliberation on reproductive health care access, the Brigham and Women's and Harvard University expert joins to discuss the clinical matters of abortion.

Expert gynecologist Dr. Deborah Bartz addresses the clinical implications of an abortion ban if Roe v. Wade is overturned.

The azole antifungal treatment was approved by the FDA to reduce the incidence of recurrent vulvovaginal candidiasis, or chronic yeast infection.

ANCA-associated vasculitis may present like sinusitis, but it typically affects multiple organ systems.

The overall strength of association was directly related to the number of affected first-degree relatives and was modified by IBD subtype and age of diagnosis.

Erica Marsh, MD, MSCI, discusses the role of new drug classes like GnRH antagonists, as well as the adoption of remote screening options following COVID-19 response.

Erica Marsh, MD, MSCI, discusses the need for improved patient involvement and open discussion in the highly prevalent, potentially psychologically impactful condition.

Bianca K. Frogner, PhD, discusses the prevalence of burnout and job dissatisfaction observed across various health care worker roles and settings.

Data show the life expectancy of Hispanic and non-Hispanic Black Americans decreased by more than 3 years during the pandemic.

A survey analysis suggests the worst of turnover in the workforce occurred in 2020, but focus is needed to recover health care workers from specific fields.

Dr. Rafael Pérez-Figueroa talks about how the pandemic has exacerbated racial inequities on multiple levels saying that people of color have been overrepresented in jobs with high exposure to COVID-19, leading to disproportionate infections and death.

Cross-sectional analysis of national survey data suggest students with multiple marginalized identities are more prone to treatment that could lead to burnout.

In 2020 many clinics shifted to telehealth or reduced-contact practices which applied to medication abortions. Physicians relied solely on history-based screening instead of ultrasonography or pelvic exams during this time and investigators analyzed the data.

New data show the highest quintile of census-reported parental income is far more represented among future physicians than lower income levels, regardless of race.

USPSTF experts noted a need for research into the benefits and harms of screening adults and adolescents without signs or symptoms.

Research from Wake Forest shows patients are more comfortable sharing concerning matters when screened on a tablet app compared with speaking to a nurse.

Transgender and nonbinary youths, a population with an exceptional risk of suicide and poor mental health outcomes, were found to have 60% lower odds of depression after receiving gender-affirming intervention.

The CDC has estimated at least 2.4 million flu illnesses, 23,000 hospitalizations, and 1,400 deaths from flu so far this season.

Daridorexant 25 mg and 50 mg had the best results in comparison with placebo.

The Supplemental New Drug Application was based on the results of numerous clinical trials.

The number of dropouts and dropouts because of adverse events did not differ between treatments.

A 3-part series on the manifestations of physician burnout, how COVID-19 changed its scope and revealed systemic fractures, and finally, the path towards resolution and reformation.

Califf previously served as FDA commissioner under the Obama Administration after a 35-year career at Duke University.